Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis
- Conditions
- Interventions
- First Posted Date
- 2005-05-09
- Last Posted Date
- 2015-07-15
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 260
- Registration Number
- NCT00110396
- Locations
- 🇺🇸
Local US Medical Information, Rockland, Massachusetts, United States
Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency
- Conditions
- Interventions
- First Posted Date
- 2005-05-03
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 31
- Registration Number
- NCT00109733
- Locations
- 🇺🇸
Nemours Children's Clinic, Orlando, Florida, United States
🇺🇸Pediatric Endocrinology Children's Clinic, Tallahassee, Florida, United States
🇺🇸Children's Hospital of Orange County, Orange, California, United States
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
- First Posted Date
- 2005-03-16
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 506
- Registration Number
- NCT00105508
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
- First Posted Date
- 2005-03-16
- Last Posted Date
- 2018-04-02
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 398
- Registration Number
- NCT00105521
Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects
- Conditions
- First Posted Date
- 2005-01-19
- Last Posted Date
- 2013-08-06
- Lead Sponsor
- EMD Serono
- Registration Number
- NCT00101959
Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
- Conditions
- Interventions
- First Posted Date
- 2004-10-11
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 81
- Registration Number
- NCT00093964
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸Baylor University Medical Center at Dallas, Dallas, Texas, United States
🇺🇸University of Vermont/Fletcher Allen Healthcare, Burlington, Vermont, United States
Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
- First Posted Date
- 2004-08-26
- Last Posted Date
- 2013-10-22
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 854
- Registration Number
- NCT00090129
- Locations
- 🇺🇸
Academic Dermatology Associates, Albuquerque, New Mexico, United States
🇺🇸Longmont Clinic PC, Longmont, Colorado, United States
🇺🇸Scott D. Glazer, MD, Buffalo Grove, Illinois, United States
Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients
- Conditions
- Interventions
- First Posted Date
- 2004-05-17
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 326
- Registration Number
- NCT00082628
- Locations
- 🇺🇸
1640 Rhode Island Avenue, N.W., Washington, D.C., District of Columbia, United States
🇨🇦AIDS Research Program, Vancouver, British Columbia, Canada
🇺🇸Albany Medical College, Albany, New York, United States
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
- Conditions
- Interventions
- First Posted Date
- 2004-02-26
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 764
- Registration Number
- NCT00078338
- Locations
- 🇷🇺
Dept of Neurology St Petersburg State Medical University, St Petersburg, Russian Federation
🇺🇸University Of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Minor & James Medical, PLLC, Seattle, Washington, United States
Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment
- Conditions
- First Posted Date
- 2004-01-07
- Last Posted Date
- 2013-10-23
- Lead Sponsor
- EMD Serono
- Registration Number
- NCT00016237
- Locations
- 🇺🇸
Lombardi Cancer Center, Washington, District of Columbia, United States
🇺🇸Memorial Sloan-Kettering Cancer Center, New York, New York, United States